NCT06696742View on ClinicalTrials.gov

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2029

Study Completion Date

February 1, 2029

Conditions
Bladder (Urothelial, Transitional Cell) Cancer
Interventions
DRUG

Clostridium Butyricum Tablets

Gemcitabine and Cisplatin combined with Clostridium Butyricum Tablets

DRUG

Cisplatin

Gemcitabine and Cisplatin

Trial Locations (1)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER